Helminthic Immune Modulation by Schistosoma Antigens: Implications for Translational Immunotherapy

Schistosoma species, causative agents of schistosomiasis, employ sophisticated immune evasion strategies that allow chronic infection in their human hosts. Central to these strategies are antigens secreted or shed by the parasite, which modulate host immune responses. These antigens not only facilitate parasite survival but also provide valuable insights into immune regulation with potential applications in treating autoimmune and inflammatory diseases. This article reviews the host immune responses to Schistosoma, key immunomodulatory antigens, mechanisms of immune modulation, and their therapeutic implications. Current challenges in translating these findings to clinical therapies are also discussed.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-22
DOI
https://doi.org/10.5281/zenodo.15489790
Primary Topic
History and advancements in chemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Helminthic Immune Modulation by Schistosoma Antigens: Implications for Translational Immunotherapy

Zenodo (CERN European Organization for Nuclear Research)
History and advancements in chemistry
article

Helminthic Immune Modulation by Schistosoma Antigens: Implications for Translational Immunotherapy

article en

Abstract

Schistosoma species, causative agents of schistosomiasis, employ sophisticated immune evasion strategies that allow chronic infection in their human hosts. Central to these strategies are antigens secreted or shed by the parasite, which modulate host immune responses. These antigens not only facilitate parasite survival but also provide valuable insights into immune regulation with potential applications in treating autoimmune and inflammatory diseases. This article reviews the host immune responses to Schistosoma, key immunomodulatory antigens, mechanisms of immune modulation, and their therapeutic implications. Current challenges in translating these findings to clinical therapies are also discussed.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 55%
History and advancements in chemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.